Opinion
Video
Author(s):
Amir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.
Urologists perform first remote robot-assisted HIFU for prostate cancer
Dr. Murphy on increasing diversity in cancer clinical trials
Study underway to assess 3-fraction SBRT regimen in prostate cancer
Dr. Schwen on focal therapies for prostate cancer
Genetic test can predict risk of toxicity following radiation for prostate cancer
What urologists can expect in Q2 of 2025